Small molecule active pharmaceutical ingredients (APIs) are becoming more molecularly complex, resulting in formidable challenges for small and emerging biotechs. Lonza’s AI-Enabled Route Scouting Service is an advanced approach to retrosynthetic analysis that provides drug development partners with clinically and commercially viable synthesis pathways towards an API.
Download the technical brief to learn more.